Publications by authors named "Jim B D Keijser"

Claim this Profile
D
Dimerization as a key feature of autoreactive IgA antibody responses.
Anouk G van Mourik, Jim B D Keijser, Myrthe A M van Delft, Sanne Reijm, Alice Bacon

Ann Rheum Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 Spike IgA2 Induces Inflammation by Human Macrophages.
Lynn Mes, Jennifer Veth, Julie Van Coillie, Jim B D Keijser, Elise Mantel

Eur J Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment.
Jim B D Keijser, Eileen W Stalman, Luuk Wieske, Maurice Steenhuis, Koos P J van Dam

EBioMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Eileen W Stalman, Luuk Wieske, Jim B D Keijser, Koos P J van Dam, Laura Y L Kummer

J Allergy Clin Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Anika M Valk, Jim B D Keijser, Koos P J van Dam, Eileen W Stalman, Luuk Wieske

Allergy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
Sofie Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, Maurice Steenhuis, Jim B D Keijser

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.
Julie Van Coillie, Tamas Pongracz, Tonći Šuštić, Wenjun Wang, Jan Nouta, Jim B D Keijser

iScience· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, Eileen W Stalman, Laura Y L Kummer, Jim B D Keijser

BMC Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, Laura Y L Kummer, Jesse Roosen, Jim B D Keijser

J Autoimmun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Eileen W Stalman, Luuk Wieske, Koos P J van Dam, Laura Y Kummer, Zoé L E van Kempen, Jim B D Keijser

Ann Rheum Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination.
Koos P J van Dam, Laura Hogenboom, Eileen W Stalman, Laura Y L Kummer, Maurice Steenhuis, Jim B D Keijser

Front Neurol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, Eileen W Stalman, Laura Y L Kummer, Jim B D Keijser

Lancet Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis